InvestorsHub Logo
Followers 89
Posts 17441
Boards Moderated 0
Alias Born 09/06/2006

Re: learningcurve2020 post# 639767

Thursday, 10/12/2023 12:46:31 PM

Thursday, October 12, 2023 12:46:31 PM

Post# of 702671

Wondering if anyone saw Mulholland's recent comment. Seems like he'd know.


Fairly clear. Dr Mulholland, a DCVax-L supporter, states the need to get trials going to get a new drug approved.

Paul Mulholland, a consultant in medical oncology at University College London hospitals NHS foundation trust, who treated Margaret privately, supports Siobhain’s campaign and says some drug firms are reluctant to provide drugs for trials because they say it is not financially viable to develop treatments for glioblastoma. He said: “The tumours that are less common get left behind. The treatment will be the same in 10 years’ time if we don’t do trials. We need to partner with the NHS and the pharmaceutical industry to get the trials for brain cancer patients.” He believes an effective treatment can be found within seven years with a comprehensive schedule of trials.[/quote

Reasonable timeline for somebody who does not expect a current P3 to yield approval.
.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News